Endovascular Therapy of Superficial Femoral Artery and Popliteal Lesions in Critical Limb Ischemia

INTRODUCTION In most developed countries, the incidence of severe limb ischemia is estimated to be approximately 50 to 100 patients per 100,000 every year. Despite advances in medical therapy, the prospects are that this number will most likely even increase in the near future, due to an ageing population, the increasing prevalence of diabetes, and the sustained tobacco consumption (1,2).